Back to search

United States· US:72789-528_3e794c61-ef94-8751-e063-6294a90aafc4

Minocycline Hydrochloride

A minocycline product containing minocycline hydrochloride, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 10 of our 19 countries.

ATC J01AA08US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMinocycline HydrochlorideATCJ01AA08REGISTER NO.US:72789-528_3e794c61…PACKS LISTED2CHECKEDAugust 2, 2026

Where it is registered

Minocycline is registered in 10 of 19 countries.

Countries holding a registration under ATC J01AA08 (minocycline), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose

Minocycline · ATC J01AA08

10 / 19 countries

  • Belgiumprice
  • Canada
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
MINOCYCLINE HYDROCHLORIDE
Manufacturer
PD-Rx Pharmaceuticals, Inc.
Country
United States (US)
ATC code
J01AA08
ATC class
Minocycline
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
August 2, 2026

Packs & prices · 2

  • ndc11
    72789-528-30
  • ndc11
    7278952830
    30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-528-30)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

367 interactions on record for minocycline.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Minocycline · interactions on record

367 records

  • 15 severe
  • 142 moderate
  • 28 minor
  • 128 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • AcitretinD05BB02severe
  • IsotretinoinD10AD04severe

54 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Minocycline in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All minocycline products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Minostad
  • Belgium · Klinotab, Mino-50
  • Bulgaria · Миноциклин Екофарм
  • Cyprus · Minaxen
  • Germany · Minoplus, Skid
  • Spain · Minocin Vía Oral
  • France · Kyno, Mynocine
  • United Kingdom (Northern Ireland) · Dentomycin, Minocin Mr
  • Greece · Minocin
  • Ireland · Minocin Sa, Minosil
  • Italy · Minocin
  • Luxembourg · Klinotab, Mino
  • Malta · Minaxen
  • Netherlands · Minocycline Eurogenerics, Minocycline Hydrochloride Dihydrate Aurobindo
  • Portugal · Cipancin, Minocin
  • Romania · Minoz Ep

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f30804b9-d4b6-4d43-8921-41abb4acf8d0
GET /v1/drugs/f30804b9-d4b6-4d43-8921-41abb4acf8d0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "105",
  "substance": "MINOCYCLINE HYDROCHLORIDE",
  "productndc": "72789-528",
  "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA204453",
  "marketing_category": "ANDA"
}

See everything about minocycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.